SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

75,197.00 -380.58
( -0.50%)

Global Indices

Nasdaq

52,820.00 -615.25
(-1.15%)

Dow Jones

7,695.68 -43.92
(-0.57%)

Hang Seng

65,089.68 -179.65
(-0.28%)

Nikkei 225

10,811.26 -10.87
(-0.10%)

Forex

USD-INR

94.51 0.08
(0.08%)

EUR-INR

109.83 0.16
(0.15%)

GBP-INR

127.88 0.26
(0.20%)

JPY-INR

0.61 0.01
(0.93%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Oxygenta Pharmaceutical Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524636

INE102E01018

-11.5421201

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

205.15

EPS(TTM)

Face Value()

Div & Yield %

Back

IRB InvIT Fund consolidated net profit declines 20.24% in the June 2026 quarter

Jul 23,2026

Net profit of IRB InvIT Fund declined 20.24% to Rs 79.44 crore in the quarter ended June 2026 as against Rs 99.60 crore during the previous quarter ended June 2025. Sales rose 69.28% to Rs 492.16 crore in the quarter ended June 2026 as against Rs 290.74 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	492.16	290.74	69
OPM %	80.51	84.14	-
PBDT	208.14	172.13	21
PBT	80.37	101.52	-21
NP	79.44	99.60	-20

75,197.00 -380.58 ( -0.50%)

52,820.00 -615.25 (-1.15%)

7,695.68 -43.92 (-0.57%)

65,089.68 -179.65 (-0.28%)

10,811.26 -10.87 (-0.10%)

94.51 0.08 (0.08%)

109.83 0.16 (0.15%)

127.88 0.26 (0.20%)

0.61 0.01 (0.93%)